Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Signs Reseller Agreement With Illumina

NEW YORK (GenomeWeb) – Molecular diagnostics company GenDx has signed an agreement with Illumina Netherlands making GenDx a non-exclusive reseller of Illumina products in certain countries.

Under the terms of the agreement, GenDx can sell Illumina's next-generation sequencing instruments, reagents, and maintenance contracts for the field of HLA sequencing, including GenDx's proprietary HLA-NGSgo reagents and NGSengine software for allelic level HLA typing analysis. GenDx's distribution will take place in Italy, the UK, Germany, Belgium, the Netherlands, Luxembourg, and Finland.

GenDx CEO Wietse Mulder said in a statement that the agreement with Illumina will complement his company's HLA typing offerings and reinforce its leading position in the HLA typing field.